Listen to this article

The basics:

• Opinion: Kimberly-Clark–Kenvue merger analyzed through antitrust lens
• Companies operate in complementary consumer health segments
• Deal projected to generate about $2B in annual cost savings
• Merger could strengthen New Jersey’s consumer health innovation hub

As merger activity begins to rebound after a prolonged slowdown, regulators and the public are once again debating what makes a deal “good” or “bad” for consumers.

The proposed merger between Kimberly-Clark Corp. and Kenvue Inc. offers a useful case study — one that highlights how carefully structured mergers can preserve consumer choice, generate efficiencies, and strengthen U.S. competitiveness without reducing competition.

Kimberly-Clark is best known for hygiene and paper products, while Kenvue’s portfolio is concentrated in over-the-counter health, skin care and oral care. These companies operate in largely non-overlapping product categories, which means they are not in head-to-head competition in consumer markets. This merger, then, does not eliminate competition between two rivals, but instead brings together firms that operate at different points in complementary segments within the broader consumer health and hygiene business.

This distinction is important in antitrust analysis. The government’s role in reviewing mergers focuses on preventing transactions that reduce competition, raise prices, or restrict consumer choice. The proposed Kimberly-Clark and Kenvue merger combines correlative products rather than eliminating competition.

From an economic standpoint, the deal is expected to generate roughly $2 billion in annual cost savings through shared supply chains and infrastructure. Many of the companies’ brands already rely on similar manufacturing processes, logistics networks, and distribution channels. Integrating these systems reduces duplication, improves reliability, and lowers per-unit costs. In consumer goods markets – where there is already ample competition in hygiene, personal care and skin care categories – competitive pressure makes it likely that cost savings are passed through to consumers rather than absorbed as excess profit.

Local impact

There is also a regional dimension worth noting. Kenvue is headquartered in New Jersey, home to a deep life-sciences and consumer-health talent base. Integrating Kimberly-Clark’s R&D capabilities into that ecosystem strengthens New Jersey’s role as a hub for consumer health innovation, while keeping high-value research and development jobs in the United States.

The New Jersey regional economic implications extend beyond corporate balance sheets. Investment decisions tied to headquarters, laboratories, and advanced manufacturing facilities are more likely to support local employment, supplier networks, and create innovation spillovers.

This is important as the combined firm would emerge as a roughly $32 billion U.S.-based consumer health and hygiene leader. Global consumer goods markets are increasingly dominated by large non-U.S. firms, including companies such as Unilever, which recently touted the U.S. market as the firm’s growth leader. Ensuring that American companies are positioned to compete in expanding global consumer markets is not just a unique business concern, but an economic opportunity. Scale can enable U.S. firms to invest, innovate, and compete internationally while maintaining domestic operations.

Antitrust scrutiny plays an essential role in protecting consumers and markets. But scrutiny should be grounded in economic analysis, not automatic distrust of mergers. Blocking transactions simply to appear tough on business risks unintended consequences, including higher costs to consumers, weaker innovation and diminished global competitiveness.

When assessed through the lens of competition policy, the Kimberly-Clark–Kenvue transaction differs from mergers that raise legitimate antitrust concerns. The deal does not consolidate competing brands or reduce consumer options, and its primary effects are structural and operational rather than exclusionary.

There is no question that consolidation in some industries has harmed consumers, reduced choice, and raised prices. But those outcomes are not inevitable, and they should not be presumed in every transaction. This deal is a reminder that not all mergers are alike, and that well-designed combinations can advance the very consumer interests antitrust law is meant to protect.

Danielle Zanzalari is an assistant professor of Economics at Seton Hall University. She frequently researches financial regulation, public finance and an array of economic efficiency issues.